Two Sides of Nanovaccines and Nanomedicines in Cancer Treatments
Published on 25. March 2026
230 pages
978-0-443-44580-4 (ISBN)
Description
Two Sides of Nanovaccines and Nanomedicines in Cancer Treatments provides a balanced exploration of the dual roles of nanotechnologies in oncology. Structured in four parts, the book begins with foundational knowledge of nanovaccines and nanomedicines, detailing their applications in cancer care and highlighting their precision in targeting cancer cells while reducing systemic toxicity. Importantly, the book addresses potential drawbacks, discussing side effects and safety concerns associated with these innovations. The final section emphasizes ethical, regulatory, and safety challenges, underscoring the need for careful oversight as nanotechnologies advance.For the academic audience, this book serves as a vital resource, offering insights that equip researchers and healthcare professionals to make informed decisions regarding clinical applications. Its focus on both benefits and risks, alongside forward-looking perspectives, ensures that readers are well-prepared for future developments in the field of nanomedicine and cancer therapy.
- Provides an in-depth foundation on nanovaccines and nanomedicines, detailing their mechanisms, roles, and applications in cancer treatment
- Addresses both the advantages and potential side effects of nanovaccines and nanomedicines
- Emphasizes the ethical, safety, and regulatory aspects of nanotechnology in cancer therapy, offering valuable guidance for responsible usage and oversight in clinical settings
More details
Other editions
Additional editions
Tuan Anh Nguyen | Bhupendra G. Prajapati | Devesh U. Kapoor
Two Sides of Nanovaccines and Nanomedicines in Cancer Treatments
Book
approx. 04/2026
Academic Press
€171.50
Not yet published
Content
Part 1: Fundamentals1. Introduction to nanovaccine in cancer treatments2. Introduction to nanomedicine in cancer treatments3. Sensors for Cancer Detection4. Current Perspectives of Nanomedicines (in Cancer Treatment)5. Current Perspectives of Nanovaccines and Nanomedicines (in Cancer Treatment)Part 2: Advantage and Application of Nanovaccine and Nanomedicine6. Advantage of cancer Nanomedicine7. Advantage of Targeted Nanomedicine (in Cancer Treatment)8. Advantage of nanovaccine (in cancer treatment)9. Nanovaccines and Nanomedicines in cancer treatment: Current LandscapePart 3: The Other Side of Nanovaccine and Nanomedicine10. Side Effect and Toxicity of Nanovaccine (in Cancer Treatment)11. Side effect and toxicity of nanomedicine (in cancer treatment)12. Crossing the Barrier, Crossing the Line: Neurotoxicity of Nanomedicines in Brain Cancer Therapy 13. Side effects and toxicity of nanoparticles in cancer treatment14. Toxicity of Metal Oxide Nanoparticles in Nanomedicine. Mechanisms and Implications15. Nanotoxicity, safety assessment, regulatory aspect and clinical trial of nanovaccines/nanomedicine16. Nanotoxicity/nano-genotoxicity in cancer care17. Toxicity evaluation and management for nanoparticles used in the cancer therapy18. Nanoparticle Toxicity in Cancer NanomedicinePart 4: Challenge and Perspectives19. Nano-medicines and Nano-vaccines Manufacturing20. Ethics in Nanomedicine and Nanovaccine in Cancer Treatment21. Ethics in Cancer Nanomedicine22. Ethics and regulations in nanomedicine/nanovaccines23. Regulating nanomedicine: challenges and opportunities24. Safety Assessment for Nanomedicines and Nanovaccines25. Manufacturing of nanomedicine/nanovaccine on Large Scale: Challenges and Issues26. Future perspectives of nanovaccines and nanomedicines
